Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Masashi Miyauchi, MD, PhD, Shunya Arai, MD, PhD, Akira Honda, MD PhD, Sho Yamazaki, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Kazuki Taoka, MD, PhD, Keiki Kumano, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2016) 128 (22): 1878.

https://doi.org/10.1182/blood.V128.22.1878.1878

Published: 2016

Journal Articles

The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells

Chiharu I. Kobayashi, Keiyo Takubo, Hiroshi Kobayashi, Ayako Nakamura-Ishizu, Hiroaki Honda, Keisuke Kataoka, Keiki Kumano, Hideo Akiyama, Tetsuo Sudo, Mineo Kurokawa, Toshio Suda

Blood (2014) 123 (16): 2540–2549.

https://doi.org/10.1182/blood-2013-07-517847

Published: 2014

Includes: Supplemental data

Journal Articles

Disease-Specific Induced Pluripotent Stem Cells Recapitulate The Pathophysiology Of Familial Platelet Disorder With Predisposition To Acute Myelogenous Leukemia

Shunya Arai, MD, PhD, Hiromitsu Iiduka, MD, Naoya Takayama, M.D., Ph.D., Miyauchi Masashi, MD, Kazuki Taoka, MD, PhD, Keisuke Kataoka, MD, PhD, Masataka Hosoi, MD, PhD, Keiki Kumano, MD, PhD, Koji Eto, M.D., Ph.D., Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 1188.

https://doi.org/10.1182/blood.V122.21.1188.1188

Published: 2013

Journal Articles

Modeling Chronic Myelomonocytic Leukemia Through Patient-Derived Induced Pluripotent Stem Cells

Keisuke Kataoka, MD, PhD, Kazuki Taoka, MD, PhD, Masashi Miyauchi, M.D., Ph.D., Masataka Hosoi, M.D., Ph.D., Keiki Kumano, MD, PhD, Shunya Arai, MD, PhD, Kazuhiro Toyama, M.D., Ph.D., Genta Nagae, M.D., Ph.D., Wei Qu, Ph.D., Shinichi Morishita, Ph.D., Hiroyuki Aburatani, M.D., Ph.D., Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 864.

https://doi.org/10.1182/blood.V122.21.864.864

Published: 2013

Journal Articles

The shortest isoform of C/EBPβ , liver inhibitory protein ( LIP ), collaborates with Evi1 to induce AML in a mouse BMT model

Naoko Watanabe-Okochi, Akihide Yoshimi, Tomohiko Sato, Toshiyuki Ikeda, Keiki Kumano, Kazuki Taoka, Yumiko Satoh, Akihito Shinohara, Takako Tsuruta, Akiko Masuda, Hiromitsu Yokota, Yutaka Yatomi, Koki Takahashi, Jiro Kitaura, Toshio Kitamura, Mineo Kurokawa

Blood (2013) 121 (20): 4142–4155.

https://doi.org/10.1182/blood-2011-07-368654

Published: 2013

Includes: Supplemental data

Journal Articles

Inhibition of EZH2 Depletes MLL Fusion Leukemia Stem Cells Through Restoration of p16 Expression

Koki Ueda, Akihide Yoshimi, Masahiro Nakagawa, Satoshi Nishikawa, Victor E Marquez, Keiki Kumano, Mineo Kurokawa, M.D.

Blood (2012) 120 (21): 3510.

https://doi.org/10.1182/blood.V120.21.3510.3510

Published: 2012

Journal Articles

NF-κB/TNF-α Positive Feedback Loop with Active Proteasome Machinery Supports Myeloid Leukemia Initiating Cell Capacity

Yuki Kagoya, Akihide Yoshimi, Shunya Arai, M.D., Keisuke Kataoka, Masahiro Nakagawa, Keiki Kumano, Mineo Kurokawa

Blood (2012) 120 (21): 654.

https://doi.org/10.1182/blood.V120.21.654.654

Published: 2012

Journal Articles

Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples

Keiki Kumano, Shunya Arai, Masataka Hosoi, Kazuki Taoka, Naoya Takayama, Makoto Otsu, Genta Nagae, Koki Ueda, Kumi Nakazaki, Yasuhiko Kamikubo, Koji Eto, Hiroyuki Aburatani, Hiromitsu Nakauchi, Mineo Kurokawa

Blood (2012) 119 (26): 6234–6242.

https://doi.org/10.1182/blood-2011-07-367441

Published: 2012

Includes: Supplemental data

Journal Articles

AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

Masahiro Nakagawa, Munetake Shimabe, Naoko Watanabe-Okochi, Shunya Arai, Akihide Yoshimi, Akihito Shinohara, Nahoko Nishimoto, Keisuke Kataoka, Tomohiko Sato, Keiki Kumano, Yasuhito Nannya, Motoshi Ichikawa, Yoichi Imai, Mineo Kurokawa

Blood (2011) 118 (25): 6626–6637.

https://doi.org/10.1182/blood-2010-12-326710

Published: 2011

Includes: Supplemental data

Journal Articles

Regulation of Chronic Myelogenous Leukemia Stem Cells by Leukemia Oncogene Evi1

Tomohiko Sato, Susumu Goyama, Keisuke Kataoka, Takako Tsuruta, Masahiro Nakagawa, Keiki Kumano, Katsuyoshi Kumagai, Naoto Kubota, Takashi Kadowaki, Mineo Kurokawa, MD

Blood (2011) 118 (21): 964.

https://doi.org/10.1182/blood.V118.21.964.964

Published: 2011

Journal Articles

BAALC Regulates Hematopoietic Stem Cells Through P53 and Promotes Leukemia with Impaired P53 Function

Sumimasa Nagai, Keiki Kumano, Akihito Shinohara, Masahiro Nakagawa, Motoshi Ichikawa, Mineo Kurokawa

Blood (2011) 118 (21): 48.

https://doi.org/10.1182/blood.V118.21.48.48

Published: 2011

Journal Articles

Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19 ARF

Nahoko Nishimoto, Shunya Arai, Motoshi Ichikawa, Masahiro Nakagawa, Susumu Goyama, Keiki Kumano, Tsuyoshi Takahashi, Yasuhiko Kamikubo, Yoichi Imai, Mineo Kurokawa

Blood (2011) 118 (9): 2541–2550.

https://doi.org/10.1182/blood-2010-10-315440

Published: 2011

Journal Articles

Notch2 signaling is required for proper mast cell distribution and mucosal immunity in the intestine

Mamiko Sakata-Yanagimoto, Toru Sakai, Yasuyuki Miyake, Toshiki I. Saito, Haruhiko Maruyama, Yasuyuki Morishita, Etsuko Nakagami-Yamaguchi, Keiki Kumano, Hideo Yagita, Masashi Fukayama, Seishi Ogawa, Mineo Kurokawa, Koji Yasutomo, Shigeru Chiba

Blood (2011) 117 (1): 128–134.

https://doi.org/10.1182/blood-2010-07-289611

Published: 2011

Includes: Supplemental data

Journal Articles

Generation of Induced Pluripotent Stem Cells From Primary Chronic Myelogenous Leukemia Patient Sample.

Keiki Kumano, Shunya Arai, Koki Ueda, Kumi Nakazaki, Yasuhiko Kamikubo, Mineo Kurokawa

Blood (2010) 116 (21): 1206.

https://doi.org/10.1182/blood.V116.21.1206.1206

Published: 2010

Journal Articles

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia

Fumio Nakahara, Mamiko Sakata-Yanagimoto, Yukiko Komeno, Naoko Kato, Tomoyuki Uchida, Kyoko Haraguchi, Keiki Kumano, Yuka Harada, Hironori Harada, Jiro Kitaura, Seishi Ogawa, Mineo Kurokawa, Toshio Kitamura, Shigeru Chiba

Blood (2010) 115 (14): 2872–2881.

https://doi.org/10.1182/blood-2009-05-222836

Published: 2010

Includes: Supplemental data

Journal Articles

Plasma Brain Natriuretic Peptide Is Associated with Hepatic Veno-Occlusive Disease and Early Mortality After Allogeneic Hematopoietic Stem Cell Transplantation.

Keisuke Kataoka, Yasuhito Nannya, Hiroshi Iwata, Sachiko Seo, Keiki Kumano, Tsuyoshi Takahashi, Ryozo Nagai, Mineo Kurokawa

Blood (2009) 114 (22): 3348.

https://doi.org/10.1182/blood.V114.22.3348.3348

Published: 2009

Journal Articles

Impact On Survival and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.

Koki Ueda, Takeyuki Watadani, Eriko Maeda, Satoshi Ota, Keisuke Kataoka, Sachiko Seo, Keiki Kumano, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Kuni Ohtomo, Masashi Fukayama, Yasuhito Nannya, Mineo Kurokawa

Blood (2009) 114 (22): 3318.

https://doi.org/10.1182/blood.V114.22.3318.3318

Published: 2009

Journal Articles

Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

Akio Shigematsu, MD, PhD, Junji Tanaka, MD, PhD, Ritsuro Suzuki, MD, PhD, Takakazu Kawase, MD, PhD, Hideki Akiyama, Takahiro Fukuda, Keiki Kumano, MD, PhD, Fumiaki Yoshiba, Heiwa Kanamori, Naoki Kobayashi, Takashi Fukuhara, Masahiro Imamura, MD, PhD

Blood (2009) 114 (22): 2306.

https://doi.org/10.1182/blood.V114.22.2306.2306

Published: 2009

Journal Articles

Monitoring Trough Concentration of Voriconazole Is Important to Ensure Successful Antifungal Therapy and to Avoid Hepatic Damage in Patients with Hematological Disorders.

Yasuhito Nannya, Koki Ueda, Keiki Kumano, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Mineo Kurokawa

Blood (2009) 114 (22): 4731.

https://doi.org/10.1182/blood.V114.22.4731.4731

Published: 2009

Journal Articles

Unique Gain-of-Function of Mutated c-CBL Tumor Suppresor in Myeloid Neoplasms.

Blood (2009) 114 (22): 2970.

https://doi.org/10.1182/blood.V114.22.2970.2970

Published: 2009

NARROW

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells

Disease-Specific Induced Pluripotent Stem Cells Recapitulate The Pathophysiology Of Familial Platelet Disorder With Predisposition To Acute Myelogenous Leukemia

Modeling Chronic Myelomonocytic Leukemia Through Patient-Derived Induced Pluripotent Stem Cells

The shortest isoform of C/EBPβ , liver inhibitory protein ( LIP ), collaborates with Evi1 to induce AML in a mouse BMT model

Inhibition of EZH2 Depletes MLL Fusion Leukemia Stem Cells Through Restoration of p16 Expression

NF-κB/TNF-α Positive Feedback Loop with Active Proteasome Machinery Supports Myeloid Leukemia Initiating Cell Capacity

Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples

AML1/RUNX1 functions as a cytoplasmic attenuator of NF-κB signaling in the repression of myeloid tumors

Regulation of Chronic Myelogenous Leukemia Stem Cells by Leukemia Oncogene Evi1

BAALC Regulates Hematopoietic Stem Cells Through P53 and Promotes Leukemia with Impaired P53 Function

Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19 ARF

Notch2 signaling is required for proper mast cell distribution and mucosal immunity in the intestine

Generation of Induced Pluripotent Stem Cells From Primary Chronic Myelogenous Leukemia Patient Sample.

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia

Plasma Brain Natriuretic Peptide Is Associated with Hepatic Veno-Occlusive Disease and Early Mortality After Allogeneic Hematopoietic Stem Cell Transplantation.

Impact On Survival and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.

Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

Monitoring Trough Concentration of Voriconazole Is Important to Ensure Successful Antifungal Therapy and to Avoid Hepatic Damage in Patients with Hematological Disorders.

Unique Gain-of-Function of Mutated c-CBL Tumor Suppresor in Myeloid Neoplasms.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only